Deregulation of DNA Double-Strand Break Repair in Multiple Myeloma: Implications for Genome Stability

Por Herrero, Ana B., San Miguel, Jesús, Gutierrez, Norma C.
Publicado no PLoS One (2015)

Molecular Genetics and Cytogenetics in Cancer

Por Sayagués, José María, Roa, Sergio, Gutierrez, Norma C., Renault, Ilana Zalcberg
Publicado em 2011

Molecular Mechanisms of p53 Deregulation in Cancer: An Overview in Multiple Myeloma

Por Herrero, Ana B., Rojas, Elizabeta A., Misiewicz-Krzeminska, Irena, Krzeminski, Patryk, Gutiérrez, Norma C.
Publicado no Int J Mol Sci (2016)

Improving overall survival and overcoming adverse prognosis in the treatment of cytogenetically high-risk multiple myeloma

Por Bergsagel, P. Leif, Mateos, María-Victoria, Gutierrez, Norma C., Rajkumar, S. Vincent, San Miguel, Jesús F.
Publicado em 2013

Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair

Por Castaño, Julio, Herrero, Ana B., Bursen, Aldeheid, González, Federico, Marschalek, Rolf, Gutiérrez, Norma C., Menendez, Pablo
Publicado no Oncotarget (2016)

<it>In silico </it>whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions

Por Churkin Alexander, Barash Danny, Gutiérrez Norma C, López-Pérez Ricardo, Navratil Vincent, Aouacheria Abdel, Mouchiroud Dominique, Gautier Christian
Publicado em 2007-01-01

In silico whole-genome screening for cancer-related single-nucleotide polymorphisms located in human mRNA untranslated regions

Por Aouacheria, Abdel, Navratil, Vincent, López-Pérez, Ricardo, Gutiérrez, Norma C, Churkin, Alexander, Barash, Danny, Mouchiroud, Dominique, Gautier, Christian
Publicado em 2007

Overexpression of the VAV proto-oncogene product is associated with B-cell chronic lymphocytic leukaemia displaying loss on 13q

Por Prieto-Sánchez, Rosario M., Hernández, José A., García, Juan L., Gutiérrez, Norma C., Miguel, Jesús San, Bustelo, Xosé R., Hernández, Jesús M.
Publicado em 2006

Molecular Characterization of the Region 7q22.1 in Splenic Marginal Zone Lymphomas

Por Robledo, Cristina, García, Juan L., Benito, Rocío, Flores, Teresa, Mollejo, Manuela, Martínez-Climent, José Ángel, García, Eva, Gutiérrez, Norma C., Piris, Miguel A., Hernández, Jesús M.
Publicado em 2011

CD20 positive cells are undetectable in the majority of multiple myeloma cell lines and are not associated with a cancer stem cell phenotype

Por Paíno, Teresa, Ocio, Enrique M., Paiva, Bruno, San-Segundo, Laura, Garayoa, Mercedes, Gutiérrez, Norma C., Sarasquete, M. Eugenia, Pandiella, Atanasio, Orfao, Alberto, San Miguel, Jesús F.
Publicado em 2012

CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features

Por Schmidt-Hieber, Martin, Pérez-Andrés, Martin, Paiva, Bruno, Flores-Montero, Juan, Perez, Jose J., Gutierrez, Norma C., Vidriales, Maria-Belen, Matarraz, Sergio, San Miguel, Jesus F., Orfao, Alberto
Publicado em 2011

Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomat...

Por Sarasquete, María E., Gutiérrez, Norma C., Misiewicz-Krzeminska, Irena, Paiva, Bruno, Chillón, María C., Alcoceba, Miguel, García-Sanz, Ramón, Hernández, Jesús M., González, Marcos, San-Miguel, Jesús F.
Publicado em 2011

DEPTOR maintains plasma cell differentiation and favorably affects prognosis in multiple myeloma

Por Quwaider, Dalia, Corchete, Luis A., Misiewicz-Krzeminska, Irena, Sarasquete, María E., Pérez, José J., Krzeminski, Patryk, Puig, Noemí, Mateos, María Victoria, García-Sanz, Ramón, Herrero, Ana B., Gutiérrez, Norma C.
Publicado no J Hematol Oncol (2017)

Genomic analysis of high-risk smoldering multiple myeloma

Por López-Corral, Lucía, Mateos, María Victoria, Corchete, Luis A., Sarasquete, María Eugenia, de la Rubia, Javier, de Arriba, Felipe, Lahuerta, Juan-José, García-Sanz, Ramón, San Miguel, Jesús F., Gutiérrez, Norma C.
Publicado em 2012

Restoration of microRNA-214 expression reduces growth of myeloma cells through positive regulation of P53 and inhibition of DNA replication

Por Misiewicz-Krzeminska, Irena, Sarasquete, María E., Quwaider, Dalia, Krzeminski, Patryk, Ticona, Fany V., Paíno, Teresa, Delgado, Manuel, Aires, Andreia, Ocio, Enrique M., García-Sanz, Ramón, San Miguel, Jesús F., Gutiérrez, Norma C.
Publicado em 2013

Phenotypic, Genomic and Functional Characterization Reveals No Differences between CD138(++) and CD138(low) Subpopulations in Multiple Myeloma Cell Lines

Por Paíno, Teresa, Sarasquete, María E., Paiva, Bruno, Krzeminski, Patryk, San-Segundo, Laura, Corchete, Luis A., Redondo, Alba, Garayoa, Mercedes, García-Sanz, Ramón, Gutiérrez, Norma C., Ocio, Enrique M., San-Miguel, Jesús F.
Publicado em 2014

Integrative analysis of DNA copy number, DNA methylation and gene expression in multiple myeloma reveals alterations related to relapse

Por Krzeminski, Patryk, Corchete, Luis A., García, Juan L., López-Corral, Lucía, Fermiñán, Encarna, García, Eva M., Martín, Ana A., Hernández-Rivas, Jesús M., García-Sanz, Ramón, Miguel, Jesús F. San, Gutiérrez, Norma C.
Publicado no Oncotarget (2016)

Cytogenetic profiles in multiple myeloma and monoclonal gammopathy of undetermined significance: a study in highly purified aberrant plasma cells

Por Schmidt-Hieber, Martin, Gutiérrez, María Laura, Pérez-Andrés, Martin, Paiva, Bruno, Rasillo, Ana, Tabernero, Maria Dolores, Sayagués, José Maria, Lopez, Antonio, Bárcena, Paloma, Sanchez, María Luz, Gutiérrez, Norma C., San Miguel, Jesus F., Orfao, Alberto
Publicado em 2013

The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma

Por Paiva, Bruno, Chandia, Mauricio, Puig, Noemi, Vidriales, Maria-Belen, Perez, Jose J., Lopez-Corral, Lucia, Ocio, Enrique M., Garcia-Sanz, Ramon, Gutierrez, Norma C., Jimenez-Ubieto, Ana, Lahuerta, Juan-José, Mateos, Maria-Victoria, San Miguel, Jesús F.
Publicado no Haematologica (2015)

Synergistic DNA-damaging effect in multiple myeloma with the combination of zalypsis, bortezomib and dexamethasone

Por López-Iglesias, Ana-Alicia, González-Méndez, Lorena, San-Segundo, Laura, Herrero, Ana B., Hernández-García, Susana, Martín-Sánchez, Montserrat, Gutiérrez, Norma C., Paíno, Teresa, Avilés, Pablo, Mateos, María-Victoria, San-Miguel, Jesús F., Garayoa, Mercedes, Ocio, Enrique M.
Publicado no Haematologica (2017)